Supplemental material
Expert Review of Vaccines
Volume 19, 2020 - Issue 12
Original Research
Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials
Marta C. Nunesa Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;b Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
https://orcid.org/0000-0003-3788-878XView further author information
https://orcid.org/0000-0003-3788-878XView further author information, Marta Moreirac GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-5114-4472View further author information
https://orcid.org/0000-0002-5114-4472View further author information, , , , Clare L. Cutlanda Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;b Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africahttps://orcid.org/0000-0001-8250-8307View further author information
https://orcid.org/0000-0001-8250-8307View further author information, Nancy Françoisc GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-5968-0317View further author information
https://orcid.org/0000-0002-5968-0317View further author information, Sonia Schoonbroodtc GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-7008-9050View further author information
https://orcid.org/0000-0002-7008-9050View further author information, Javier Ruiz-Guiñazúc GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-6941-3100View further author information
https://orcid.org/0000-0001-6941-3100View further author information, Juan Pablo Yarzabalc GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-6490-2084View further author information
https://orcid.org/0000-0002-6490-2084View further author information, Dorota Borysc GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-9704-8462View further author information
https://orcid.org/0000-0001-9704-8462View further author information, Lode Schuermanc GSK, Wavre, Belgiumhttps://orcid.org/0000-0003-0697-6242View further author information
https://orcid.org/0000-0003-0697-6242View further author information & Shabir A. Madhia Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;b Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCorrespondence[email protected]
https://orcid.org/0000-0002-7629-0636View further author information
https://orcid.org/0000-0002-7629-0636View further author information show all